BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders. Treatable inherited rare movement disorders. Mov Disord 2018;33:21-35. [PMID: 28861905 DOI: 10.1002/mds.27140] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Liu K, Yang Z, Wang Y, Zhou H. Case Report: Severe Hypotonia Without Hyperphenylalaninemia Caused by a Homozygous GCH1 Variant: A Case Report and Literature Review. Front Genet 2022;13:929069. [DOI: 10.3389/fgene.2022.929069] [Reference Citation Analysis]
2 van Egmond ME, Lagrand TJ, Lizaitiene G, Smit M, Tijssen MAJ. A novel diagnostic approach for patients with adult-onset dystonia. J Neurol Neurosurg Psychiatry 2022:jnnp-2021-328120. [PMID: 35688632 DOI: 10.1136/jnnp-2021-328120] [Reference Citation Analysis]
3 Saleh DA, Attia AAEM. Shedding light on the phenotypic–genotypic correlation of rare treatable and potentially treatable pediatric movement disorders. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00286-w] [Reference Citation Analysis]
4 Savas A, Bayatli E, Eroglu U, Akbostanci MC. Combined Unilateral Radiofrequency Lesioning of the Motor Thalamus, Field of Forel, and Zona Incerta: A Series of Cases With Dystonia. Neurosurgery 2022. [PMID: 35049526 DOI: 10.1227/NEU.0000000000001819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liba Z, Kraus J, Necas T, Necas J, Klugar M, Krsek P. Movement disorders, cerebral palsy and vaccination. Eur J Paediatr Neurol 2022;36:143-50. [PMID: 34979476 DOI: 10.1016/j.ejpn.2021.12.006] [Reference Citation Analysis]
6 Weissbach A, Pauly MG, Herzog R, Hahn L, Halmans S, Hamami F, Bolte C, Camargos S, Jeon B, Kurian MA, Opladen T, Brüggemann N, Huppertz HJ, König IR, Klein C, Lohmann K. Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review. Mov Disord 2021. [PMID: 34908184 DOI: 10.1002/mds.28874] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Pollini L, Tijssen MAJ. A diagnosis of progressive myoclonic ataxia guided by blood biomarkers: Expert commentary. Parkinsonism Relat Disord 2021:S1353-8020(21)00445-4. [PMID: 34896024 DOI: 10.1016/j.parkreldis.2021.12.001] [Reference Citation Analysis]
8 Cociasu I, Sorbera C, Tuttolomondo A, Morgante F. Anderson-Fabry Disease: A Rare Cause of Levodopa-Responsive Early-Onset Parkinsonism. Mov Disord Clin Pract 2021;8:S32-4. [PMID: 34514044 DOI: 10.1002/mdc3.13283] [Reference Citation Analysis]
9 Mor-Shaked H, Paz-Ebstein E, Basal A, Ben-Haim S, Grobe H, Heymann S, Israel Z, Namnah M, Nitzan A, Rosenbluh C, Saada A, Tzur T, Yanovsky-Dagan S, Zaidel-Bar R, Harel T, Arkadir D. Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing. Brain Commun 2021;3:fcab197. [PMID: 34514401 DOI: 10.1093/braincomms/fcab197] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Ebrahimi-Fakhari D, Saffari A, Pearl PL. Childhood-onset hereditary spastic paraplegia and its treatable mimics. Mol Genet Metab 2021:S1096-7192(21)00735-6. [PMID: 34183250 DOI: 10.1016/j.ymgme.2021.06.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Svetel M, Tomić A, Kresojević N, Dragašević N, Kostić V. Perspectives on the pharmacological management of dystonia. Expert Opin Pharmacother 2021;22:1555-66. [PMID: 33904811 DOI: 10.1080/14656566.2021.1919083] [Reference Citation Analysis]
12 Good JM, Atallah I, Castro Jimenez M, Benninger D, Kuntzer T, Superti-Furga A, Tran C. NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges. Genes (Basel) 2021;12:695. [PMID: 34066437 DOI: 10.3390/genes12050695] [Reference Citation Analysis]
13 Pozojevic J, Beetz C, Westenberger A. The importance of genetic testing for dystonia patients and translational research. J Neural Transm (Vienna) 2021;128:473-81. [PMID: 33876307 DOI: 10.1007/s00702-021-02329-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gatto EM, Walker RH, Gonzalez C, Cesarini M, Cossu G, Stephen CD, Balint B, Rodríguez-Violante M, Jankovic J, Morgante F, Jinnah HA; Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Society. Worldwide barriers to genetic testing for movement disorders. Eur J Neurol 2021;28:1901-9. [PMID: 33730413 DOI: 10.1111/ene.14826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kilic-Berkmen G, Wright LJ, Perlmutter JS, Comella C, Hallett M, Teller J, Pirio Richardson S, Peterson DA, Cruchaga C, Lungu C, Jinnah HA. The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies. Front Neurol 2021;12:660909. [PMID: 33897610 DOI: 10.3389/fneur.2021.660909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Grütz K, Klein C. Dystonia updates: definition, nomenclature, clinical classification, and etiology. J Neural Transm (Vienna) 2021;128:395-404. [PMID: 33604773 DOI: 10.1007/s00702-021-02314-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Frucht L, Perez DL, Callahan J, MacLean J, Song PC, Sharma N, Stephen CD. Functional Dystonia: Differentiation From Primary Dystonia and Multidisciplinary Treatments. Front Neurol 2020;11:605262. [PMID: 33613415 DOI: 10.3389/fneur.2020.605262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Herzog R, Weissbach A, Bäumer T, Münchau A. Complex dystonias: an update on diagnosis and care. J Neural Transm (Vienna) 2021;128:431-45. [PMID: 33185802 DOI: 10.1007/s00702-020-02275-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Brandsma R, van Egmond ME, Tijssen MAJ; Groningen Movement Disorder Expertise Centre. Diagnostic approach to paediatric movement disorders: a clinical practice guide. Dev Med Child Neurol 2021;63:252-8. [PMID: 33150968 DOI: 10.1111/dmcn.14721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Bledsoe IO, Viser AC, San Luciano M. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation. Neurotherapeutics 2020;17:1622-44. [PMID: 33095402 DOI: 10.1007/s13311-020-00944-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Renaud M, Tranchant C, Koenig M, Anheim M. Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker. Mov Disord 2020;35:2139-49. [PMID: 33044027 DOI: 10.1002/mds.28307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Cheema H, Bertoli-Avella AM, Skrahina V, Anjum MN, Waheed N, Saeed A, Beetz C, Perez-Lopez J, Rocha ME, Alawbathani S, Pereira C, Hovakimyan M, Patric IRP, Paknia O, Ameziane N, Cozma C, Bauer P, Rolfs A. Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. NPJ Genom Med 2020;5:44. [PMID: 33083013 DOI: 10.1038/s41525-020-00150-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chin EM, Gwynn HE, Robinson S, Hoon AH Jr. Principles of Medical and Surgical Treatment of Cerebral Palsy. Neurol Clin 2020;38:397-416. [PMID: 32279717 DOI: 10.1016/j.ncl.2020.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Forman EB, King MD, Gorman KM. Fifteen-minute consultation: Approach to investigation and management of childhood dystonia. Arch Dis Child Educ Pract Ed 2021;106:71-7. [PMID: 32928841 DOI: 10.1136/archdischild-2019-318131] [Reference Citation Analysis]
25 Amprosi M, Zech M, Steiger R, Nachbauer W, Eigentler A, Gizewski ER, Guger M, Indelicato E, Boesch S. Familial writer's cramp: a clinical clue for inherited coenzyme Q10 deficiency. Neurogenetics 2021;22:81-6. [PMID: 32830305 DOI: 10.1007/s10048-020-00624-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Baizabal-carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management. J Neural Transm 2020;127:1323-42. [DOI: 10.1007/s00702-020-02238-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Martinez-Ramirez D, Walker RH, Rodríguez-Violante M, Gatto EM; Rare Movement Disorders Study Group of International Parkinson’s Disease. Review of Hereditary and Acquired Rare Choreas. Tremor Other Hyperkinet Mov (N Y) 2020;10:24. [PMID: 32832197 DOI: 10.5334/tohm.548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 van de Wardt J, van der Stouwe AMM, Dirkx M, Elting JWJ, Post B, Tijssen MA, Helmich RC. Systematic clinical approach for diagnosing upper limb tremor. J Neurol Neurosurg Psychiatry 2020;91:822-30. [PMID: 32457087 DOI: 10.1136/jnnp-2019-322676] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
29 Gorcenco S, Ilinca A, Almasoudi W, Kafantari E, Lindgren AG, Puschmann A. New generation genetic testing entering the clinic. Parkinsonism & Related Disorders 2020;73:72-84. [DOI: 10.1016/j.parkreldis.2020.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
30 Jinnah HA. Medical and Surgical Treatments for Dystonia. Neurol Clin 2020;38:325-48. [PMID: 32279713 DOI: 10.1016/j.ncl.2020.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
31 Galosi S, Nardecchia F, Leuzzi V. Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features. Mov Disord Clin Pract 2020;7:154-66. [PMID: 32071932 DOI: 10.1002/mdc3.12897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
32 Jinnah HA. The Dystonias. Continuum (Minneap Minn) 2019;25:976-1000. [PMID: 31356290 DOI: 10.1212/CON.0000000000000747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
33 Morales-briceño H, Mohammad SS, Post B, Fois AF, Dale RC, Tchan M, Fung VSC. Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence. Brain 2020;143:751-70. [DOI: 10.1093/brain/awz345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
34 Niemann N, Jankovic J. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism & Related Disorders 2019;67:74-89. [DOI: 10.1016/j.parkreldis.2019.06.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
35 Jinnah H, Sun YV. Dystonia genes and their biological pathways. Neurobiology of Disease 2019;129:159-68. [DOI: 10.1016/j.nbd.2019.05.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
36 Mostile G, Barone R, Nicoletti A, Rizzo R, Martinelli D, Sturiale L, Fiumara A, Jankovic J, Zappia M. Hyperkinetic movement disorders in congenital disorders of glycosylation. Eur J Neurol 2019;26:1226-34. [PMID: 31132195 DOI: 10.1111/ene.14007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Brüggemann N, Klein C. Will genotype drive treatment options? Mov Disord 2019;34:1294-9. [DOI: 10.1002/mds.27699] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
38 Ebrahimi-Fakhari D, Münchau A, Stamelou M. A special issue on childhood-onset movement disorders. Mov Disord 2019;34:595-7. [PMID: 30938852 DOI: 10.1002/mds.27663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Mohammad SS, Paget SP, Dale RC. Current therapies and therapeutic decision making for childhood-onset movement disorders. Mov Disord 2019;34:637-56. [PMID: 30919519 DOI: 10.1002/mds.27661] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
40 Gatto EM, Da Prat G, Etcheverry JL, Drelichman G, Cesarini M. Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency. Brain Sci 2019;9:E30. [PMID: 30717266 DOI: 10.3390/brainsci9020030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
41 Ebrahimi‐fakhari D, Van Karnebeek C, Münchau A. Movement Disorders in Treatable Inborn Errors of Metabolism. Mov Disord 2018;34:598-613. [DOI: 10.1002/mds.27568] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
42 Petkovic S, Lohmann K. Disease-causing or benign? challenges in genetic variant interpretation and limitations of ClinVar. Mov Disord 2018;33:1271. [PMID: 30230623 DOI: 10.1002/mds.94] [Reference Citation Analysis]
43 Mcgovern EM, Roze E, Counihan TJ. The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics. Current Opinion in Neurology 2018;31:491-7. [DOI: 10.1097/wco.0000000000000576] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
44 Rossi M, Cesarini M, Gatto EM, Cammarota A, Merello M. A Treatable Rare Cause of Progressive Ataxia and Palatal Tremor. Tremor Other Hyperkinet Mov (N Y) 2018;8:538. [PMID: 29971195 DOI: 10.7916/D8X07Q2N] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Rossi M, Balint B, Millar Vernetti P, Bhatia KP, Merello M. Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options. Mov Disord Clin Pract 2018;5:373-82. [PMID: 30363394 DOI: 10.1002/mdc3.12635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
46 Lim SY, Tan AH, Ahmad-Annuar A, Schneider SA, Bee PC, Lim JL, Ramli N, Idris MI. A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy. J Mov Disord 2018;11:89-92. [PMID: 29860786 DOI: 10.14802/jmd.17082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
47 Dulovic M, Schäffer E, Leypoldt F, Balck A, Schaake S, Hinrichs F, Kirchner H, Brüggemann N, Berg D, Lohmann K. A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members. Parkinsonism Relat Disord 2018;54:116-8. [PMID: 29650490 DOI: 10.1016/j.parkreldis.2018.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Ebrahimi-Fakhari D, Hildebrandt C, Davis PE, Rodan LH, Anselm I, Bodamer O. The Spectrum of Movement Disorders in Childhood-Onset Lysosomal Storage Diseases. Mov Disord Clin Pract 2018;5:149-55. [PMID: 29930972 DOI: 10.1002/mdc3.12573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
49 Bashir H, Jankovic J. Treatment options for chorea. Expert Rev Neurother 2018;18:51-63. [PMID: 29120264 DOI: 10.1080/14737175.2018.1403899] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]